aluates Reports

$ 0.0

Automative

Global Nucleic Acid Therapeutic Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-32I16059

Global Nucleic Acid Therapeutic Market Research Report 2023

BUY CHAPTERS

Global Nucleic Acid Therapeutic Market Research Report 2025

Code: QYRE-Auto-32I16059

Report

May 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Nucleic Acid Therapeutic Market Size

The global market for Nucleic Acid Therapeutic was valued at US$ 12900 million in the year 2024 and is projected to reach a revised size of US$ 16590 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Nucleic Acid Therapeutic Market

Nucleic acid drugs, also known as nucleic acid-based therapeutics, are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.

The Nucleic Acid-Based Therapeutics Drug Market is driven by the promising potential of nucleic acid-based therapies in treating various genetic and acquired diseases, including genetic disorders, cancer, and infectious diseases. These innovative drugs utilize nucleic acids, such as DNA or RNA, to modify or regulate gene expression, correct genetic mutations, or target specific disease-associated genes. As the understanding of genomics and molecular biology advances, and personalized medicine gains traction, the demand for nucleic acid-based therapeutics continues to grow. Innovations in drug development, delivery systems, and gene editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address delivery and stability issues, ensure long-term safety and efficacy, and navigate regulatory complexities and patient acceptance. Overcoming technical and scientific hurdles, optimizing drug delivery methods, and addressing concerns about off-target effects are ongoing challenges. Additionally, the market faces competition from conventional therapies and the need for continuous research and development to unlock the full therapeutic potential of nucleic acid-based drugs. Striking a balance between providing safe, effective, and accessible nucleic acid-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Nucleic Acid-Based Therapeutics Drug Market.

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Therapeutic.

The Nucleic Acid Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nucleic Acid Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nucleic Acid Therapeutic Market Report

Report Metric	Details
Report Name	Nucleic Acid Therapeutic Market
Accounted market size in year	US$ 12900 million
Forecasted market size in 2031	US$ 16590 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antisense Oligonucleotides (ASO) siRNA mRNA
Segment by Application	Neuromuscular Diseases hATTR COVID-19 Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, Jazz Pharmaceuticals, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, Dicerna
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nucleic Acid Therapeutic Market growing?

Ans: The Nucleic Acid Therapeutic Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Nucleic Acid Therapeutic Market size in 2031?

Ans: The Nucleic Acid Therapeutic Market size in 2031 will be US$ 16590 million.

Who are the main players in the Nucleic Acid Therapeutic Market report?

Ans: The main players in the Nucleic Acid Therapeutic Market are Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, Jazz Pharmaceuticals, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, Dicerna

What are the Application segmentation covered in the Nucleic Acid Therapeutic Market report?

Ans: The Applications covered in the Nucleic Acid Therapeutic Market report are Neuromuscular Diseases, hATTR, COVID-19, Other

What are the Type segmentation covered in the Nucleic Acid Therapeutic Market report?

Ans: The Types covered in the Nucleic Acid Therapeutic Market report are Antisense Oligonucleotides (ASO), siRNA, mRNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nucleic Acid Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antisense Oligonucleotides (ASO)

1.2.3 siRNA

1.2.4 mRNA

1.3 Market by Application

1.3.1 Global Nucleic Acid Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neuromuscular Diseases

1.3.3 hATTR

1.3.4 COVID-19

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nucleic Acid Therapeutic Market Perspective (2020-2031)

2.2 Global Nucleic Acid Therapeutic Growth Trends by Region

2.2.1 Global Nucleic Acid Therapeutic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nucleic Acid Therapeutic Historic Market Size by Region (2020-2025)

2.2.3 Nucleic Acid Therapeutic Forecasted Market Size by Region (2026-2031)

2.3 Nucleic Acid Therapeutic Market Dynamics

2.3.1 Nucleic Acid Therapeutic Industry Trends

2.3.2 Nucleic Acid Therapeutic Market Drivers

2.3.3 Nucleic Acid Therapeutic Market Challenges

2.3.4 Nucleic Acid Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nucleic Acid Therapeutic Players by Revenue

3.1.1 Global Top Nucleic Acid Therapeutic Players by Revenue (2020-2025)

3.1.2 Global Nucleic Acid Therapeutic Revenue Market Share by Players (2020-2025)

3.2 Global Nucleic Acid Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nucleic Acid Therapeutic Revenue

3.4 Global Nucleic Acid Therapeutic Market Concentration Ratio

3.4.1 Global Nucleic Acid Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Therapeutic Revenue in 2024

3.5 Global Key Players of Nucleic Acid Therapeutic Head office and Area Served

3.6 Global Key Players of Nucleic Acid Therapeutic, Product and Application

3.7 Global Key Players of Nucleic Acid Therapeutic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid Therapeutic Breakdown Data by Type

4.1 Global Nucleic Acid Therapeutic Historic Market Size by Type (2020-2025)

4.2 Global Nucleic Acid Therapeutic Forecasted Market Size by Type (2026-2031)

5 Nucleic Acid Therapeutic Breakdown Data by Application

5.1 Global Nucleic Acid Therapeutic Historic Market Size by Application (2020-2025)

5.2 Global Nucleic Acid Therapeutic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nucleic Acid Therapeutic Market Size (2020-2031)

6.2 North America Nucleic Acid Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nucleic Acid Therapeutic Market Size by Country (2020-2025)

6.4 North America Nucleic Acid Therapeutic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nucleic Acid Therapeutic Market Size (2020-2031)

7.2 Europe Nucleic Acid Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nucleic Acid Therapeutic Market Size by Country (2020-2025)

7.4 Europe Nucleic Acid Therapeutic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nucleic Acid Therapeutic Market Size (2020-2031)

8.2 Asia-Pacific Nucleic Acid Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nucleic Acid Therapeutic Market Size by Region (2020-2025)

8.4 Asia-Pacific Nucleic Acid Therapeutic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nucleic Acid Therapeutic Market Size (2020-2031)

9.2 Latin America Nucleic Acid Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nucleic Acid Therapeutic Market Size by Country (2020-2025)

9.4 Latin America Nucleic Acid Therapeutic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nucleic Acid Therapeutic Market Size (2020-2031)

10.2 Middle East & Africa Nucleic Acid Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nucleic Acid Therapeutic Market Size by Country (2020-2025)

10.4 Middle East & Africa Nucleic Acid Therapeutic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sarepta Therapeutics

11.1.1 Sarepta Therapeutics Company Details

11.1.2 Sarepta Therapeutics Business Overview

11.1.3 Sarepta Therapeutics Nucleic Acid Therapeutic Introduction

11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.1.5 Sarepta Therapeutics Recent Development

11.2 Ionis Pharmaceuticals

11.2.1 Ionis Pharmaceuticals Company Details

11.2.2 Ionis Pharmaceuticals Business Overview

11.2.3 Ionis Pharmaceuticals Nucleic Acid Therapeutic Introduction

11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.2.5 Ionis Pharmaceuticals Recent Development

11.3 Alnylam

11.3.1 Alnylam Company Details

11.3.2 Alnylam Business Overview

11.3.3 Alnylam Nucleic Acid Therapeutic Introduction

11.3.4 Alnylam Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.3.5 Alnylam Recent Development

11.4 Biogen

11.4.1 Biogen Company Details

11.4.2 Biogen Business Overview

11.4.3 Biogen Nucleic Acid Therapeutic Introduction

11.4.4 Biogen Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.4.5 Biogen Recent Development

11.5 Nippon Shinyaku

11.5.1 Nippon Shinyaku Company Details

11.5.2 Nippon Shinyaku Business Overview

11.5.3 Nippon Shinyaku Nucleic Acid Therapeutic Introduction

11.5.4 Nippon Shinyaku Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.5.5 Nippon Shinyaku Recent Development

11.6 Sobi

11.6.1 Sobi Company Details

11.6.2 Sobi Business Overview

11.6.3 Sobi Nucleic Acid Therapeutic Introduction

11.6.4 Sobi Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.6.5 Sobi Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Nucleic Acid Therapeutic Introduction

11.7.4 Novartis Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 BioNTech

11.8.1 BioNTech Company Details

11.8.2 BioNTech Business Overview

11.8.3 BioNTech Nucleic Acid Therapeutic Introduction

11.8.4 BioNTech Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.8.5 BioNTech Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Nucleic Acid Therapeutic Introduction

11.9.4 Pfizer Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.9.5 Pfizer Recent Development

11.10 Moderna Therapeutics

11.10.1 Moderna Therapeutics Company Details

11.10.2 Moderna Therapeutics Business Overview

11.10.3 Moderna Therapeutics Nucleic Acid Therapeutic Introduction

11.10.4 Moderna Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.10.5 Moderna Therapeutics Recent Development

11.11 Jazz Pharmaceuticals

11.11.1 Jazz Pharmaceuticals Company Details

11.11.2 Jazz Pharmaceuticals Business Overview

11.11.3 Jazz Pharmaceuticals Nucleic Acid Therapeutic Introduction

11.11.4 Jazz Pharmaceuticals Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.11.5 Jazz Pharmaceuticals Recent Development

11.12 CureVac

11.12.1 CureVac Company Details

11.12.2 CureVac Business Overview

11.12.3 CureVac Nucleic Acid Therapeutic Introduction

11.12.4 CureVac Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.12.5 CureVac Recent Development

11.13 Regulus Therapeutics

11.13.1 Regulus Therapeutics Company Details

11.13.2 Regulus Therapeutics Business Overview

11.13.3 Regulus Therapeutics Nucleic Acid Therapeutic Introduction

11.13.4 Regulus Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.13.5 Regulus Therapeutics Recent Development

11.14 ProQR

11.14.1 ProQR Company Details

11.14.2 ProQR Business Overview

11.14.3 ProQR Nucleic Acid Therapeutic Introduction

11.14.4 ProQR Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.14.5 ProQR Recent Development

11.15 Secarna

11.15.1 Secarna Company Details

11.15.2 Secarna Business Overview

11.15.3 Secarna Nucleic Acid Therapeutic Introduction

11.15.4 Secarna Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.15.5 Secarna Recent Development

11.16 MiNA Therapeutics

11.16.1 MiNA Therapeutics Company Details

11.16.2 MiNA Therapeutics Business Overview

11.16.3 MiNA Therapeutics Nucleic Acid Therapeutic Introduction

11.16.4 MiNA Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.16.5 MiNA Therapeutics Recent Development

11.17 Sylentis

11.17.1 Sylentis Company Details

11.17.2 Sylentis Business Overview

11.17.3 Sylentis Nucleic Acid Therapeutic Introduction

11.17.4 Sylentis Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.17.5 Sylentis Recent Development

11.18 Arrowhead

11.18.1 Arrowhead Company Details

11.18.2 Arrowhead Business Overview

11.18.3 Arrowhead Nucleic Acid Therapeutic Introduction

11.18.4 Arrowhead Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.18.5 Arrowhead Recent Development

11.19 Silence Therapeutics

11.19.1 Silence Therapeutics Company Details

11.19.2 Silence Therapeutics Business Overview

11.19.3 Silence Therapeutics Nucleic Acid Therapeutic Introduction

11.19.4 Silence Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.19.5 Silence Therapeutics Recent Development

11.20 Dicerna

11.20.1 Dicerna Company Details

11.20.2 Dicerna Business Overview

11.20.3 Dicerna Nucleic Acid Therapeutic Introduction

11.20.4 Dicerna Revenue in Nucleic Acid Therapeutic Business (2020-2025)

11.20.5 Dicerna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Nucleic Acid Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antisense Oligonucleotides (ASO)

Table 3. Key Players of siRNA

Table 4. Key Players of mRNA

Table 5. Global Nucleic Acid Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Nucleic Acid Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Nucleic Acid Therapeutic Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Nucleic Acid Therapeutic Market Share by Region (2020-2025)

Table 9. Global Nucleic Acid Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Nucleic Acid Therapeutic Market Share by Region (2026-2031)

Table 11. Nucleic Acid Therapeutic Market Trends

Table 12. Nucleic Acid Therapeutic Market Drivers

Table 13. Nucleic Acid Therapeutic Market Challenges

Table 14. Nucleic Acid Therapeutic Market Restraints

Table 15. Global Nucleic Acid Therapeutic Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Nucleic Acid Therapeutic Market Share by Players (2020-2025)

Table 17. Global Top Nucleic Acid Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Therapeutic as of 2024)

Table 18. Ranking of Global Top Nucleic Acid Therapeutic Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Nucleic Acid Therapeutic Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Nucleic Acid Therapeutic, Headquarters and Area Served

Table 21. Global Key Players of Nucleic Acid Therapeutic, Product and Application

Table 22. Global Key Players of Nucleic Acid Therapeutic, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Nucleic Acid Therapeutic Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Nucleic Acid Therapeutic Revenue Market Share by Type (2020-2025)

Table 26. Global Nucleic Acid Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Nucleic Acid Therapeutic Revenue Market Share by Type (2026-2031)

Table 28. Global Nucleic Acid Therapeutic Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Nucleic Acid Therapeutic Revenue Market Share by Application (2020-2025)

Table 30. Global Nucleic Acid Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Nucleic Acid Therapeutic Revenue Market Share by Application (2026-2031)

Table 32. North America Nucleic Acid Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Nucleic Acid Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Nucleic Acid Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Nucleic Acid Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Nucleic Acid Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Nucleic Acid Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Nucleic Acid Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Nucleic Acid Therapeutic Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Nucleic Acid Therapeutic Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Nucleic Acid Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Nucleic Acid Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Nucleic Acid Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Nucleic Acid Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Nucleic Acid Therapeutic Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Nucleic Acid Therapeutic Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sarepta Therapeutics Company Details

Table 48. Sarepta Therapeutics Business Overview

Table 49. Sarepta Therapeutics Nucleic Acid Therapeutic Product

Table 50. Sarepta Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 51. Sarepta Therapeutics Recent Development

Table 52. Ionis Pharmaceuticals Company Details

Table 53. Ionis Pharmaceuticals Business Overview

Table 54. Ionis Pharmaceuticals Nucleic Acid Therapeutic Product

Table 55. Ionis Pharmaceuticals Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 56. Ionis Pharmaceuticals Recent Development

Table 57. Alnylam Company Details

Table 58. Alnylam Business Overview

Table 59. Alnylam Nucleic Acid Therapeutic Product

Table 60. Alnylam Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 61. Alnylam Recent Development

Table 62. Biogen Company Details

Table 63. Biogen Business Overview

Table 64. Biogen Nucleic Acid Therapeutic Product

Table 65. Biogen Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 66. Biogen Recent Development

Table 67. Nippon Shinyaku Company Details

Table 68. Nippon Shinyaku Business Overview

Table 69. Nippon Shinyaku Nucleic Acid Therapeutic Product

Table 70. Nippon Shinyaku Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 71. Nippon Shinyaku Recent Development

Table 72. Sobi Company Details

Table 73. Sobi Business Overview

Table 74. Sobi Nucleic Acid Therapeutic Product

Table 75. Sobi Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 76. Sobi Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Nucleic Acid Therapeutic Product

Table 80. Novartis Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. BioNTech Company Details

Table 83. BioNTech Business Overview

Table 84. BioNTech Nucleic Acid Therapeutic Product

Table 85. BioNTech Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 86. BioNTech Recent Development

Table 87. Pfizer Company Details

Table 88. Pfizer Business Overview

Table 89. Pfizer Nucleic Acid Therapeutic Product

Table 90. Pfizer Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 91. Pfizer Recent Development

Table 92. Moderna Therapeutics Company Details

Table 93. Moderna Therapeutics Business Overview

Table 94. Moderna Therapeutics Nucleic Acid Therapeutic Product

Table 95. Moderna Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 96. Moderna Therapeutics Recent Development

Table 97. Jazz Pharmaceuticals Company Details

Table 98. Jazz Pharmaceuticals Business Overview

Table 99. Jazz Pharmaceuticals Nucleic Acid Therapeutic Product

Table 100. Jazz Pharmaceuticals Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 101. Jazz Pharmaceuticals Recent Development

Table 102. CureVac Company Details

Table 103. CureVac Business Overview

Table 104. CureVac Nucleic Acid Therapeutic Product

Table 105. CureVac Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 106. CureVac Recent Development

Table 107. Regulus Therapeutics Company Details

Table 108. Regulus Therapeutics Business Overview

Table 109. Regulus Therapeutics Nucleic Acid Therapeutic Product

Table 110. Regulus Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 111. Regulus Therapeutics Recent Development

Table 112. ProQR Company Details

Table 113. ProQR Business Overview

Table 114. ProQR Nucleic Acid Therapeutic Product

Table 115. ProQR Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 116. ProQR Recent Development

Table 117. Secarna Company Details

Table 118. Secarna Business Overview

Table 119. Secarna Nucleic Acid Therapeutic Product

Table 120. Secarna Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 121. Secarna Recent Development

Table 122. MiNA Therapeutics Company Details

Table 123. MiNA Therapeutics Business Overview

Table 124. MiNA Therapeutics Nucleic Acid Therapeutic Product

Table 125. MiNA Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 126. MiNA Therapeutics Recent Development

Table 127. Sylentis Company Details

Table 128. Sylentis Business Overview

Table 129. Sylentis Nucleic Acid Therapeutic Product

Table 130. Sylentis Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 131. Sylentis Recent Development

Table 132. Arrowhead Company Details

Table 133. Arrowhead Business Overview

Table 134. Arrowhead Nucleic Acid Therapeutic Product

Table 135. Arrowhead Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 136. Arrowhead Recent Development

Table 137. Silence Therapeutics Company Details

Table 138. Silence Therapeutics Business Overview

Table 139. Silence Therapeutics Nucleic Acid Therapeutic Product

Table 140. Silence Therapeutics Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 141. Silence Therapeutics Recent Development

Table 142. Dicerna Company Details

Table 143. Dicerna Business Overview

Table 144. Dicerna Nucleic Acid Therapeutic Product

Table 145. Dicerna Revenue in Nucleic Acid Therapeutic Business (2020-2025) & (US$ Million)

Table 146. Dicerna Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. Authors List of This Report

List of Figures

Figure 1. Nucleic Acid Therapeutic Picture

Figure 2. Global Nucleic Acid Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nucleic Acid Therapeutic Market Share by Type: 2024 VS 2031

Figure 4. Antisense Oligonucleotides (ASO) Features

Figure 5. siRNA Features

Figure 6. mRNA Features

Figure 7. Global Nucleic Acid Therapeutic Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Nucleic Acid Therapeutic Market Share by Application: 2024 VS 2031

Figure 9. Neuromuscular Diseases Case Studies

Figure 10. hATTR Case Studies

Figure 11. COVID-19 Case Studies

Figure 12. Other Case Studies

Figure 13. Nucleic Acid Therapeutic Report Years Considered

Figure 14. Global Nucleic Acid Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Nucleic Acid Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Nucleic Acid Therapeutic Market Share by Region: 2024 VS 2031

Figure 17. Global Nucleic Acid Therapeutic Market Share by Players in 2024

Figure 18. Global Top Nucleic Acid Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Therapeutic as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid Therapeutic Revenue in 2024

Figure 20. North America Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Nucleic Acid Therapeutic Market Share by Country (2020-2031)

Figure 22. United States Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nucleic Acid Therapeutic Market Share by Country (2020-2031)

Figure 26. Germany Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nucleic Acid Therapeutic Market Share by Region (2020-2031)

Figure 34. China Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nucleic Acid Therapeutic Market Share by Country (2020-2031)

Figure 42. Mexico Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nucleic Acid Therapeutic Market Share by Country (2020-2031)

Figure 46. Turkey Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Nucleic Acid Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 51. Alnylam Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 52. Biogen Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 53. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 54. Sobi Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 56. BioNTech Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 58. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 60. CureVac Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 61. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 62. ProQR Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 63. Secarna Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 64. MiNA Therapeutics Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 65. Sylentis Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 66. Arrowhead Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 67. Silence Therapeutics Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 68. Dicerna Revenue Growth Rate in Nucleic Acid Therapeutic Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nucleic Acid based Therapy Market Research Report 2024

Global RNA based Therapeutics Drug Market Research Report 2024

Global Nucleic Acid Drugs Market Research Report 2025

Global Nucleic Acid Medicine Market Research Report 2025

Global RNA Therapeutics Market Research Report 2024

Global Nucleic Acid Based Gene Therapy Market Research Report 2025

Global Nucleotide based Therapeutics Market Research Report 2024

Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

Global Nucleic Acid based Drugs Market Research Report 2024

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

Global Nucleic Acid Vaccine Market Insights Forecast to 2030

Global Nucleic Acid Drug Raw Materials Market Research Report 2025

Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Nucleic Acid Therapeutic Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-32I16059

Global Nucleic Acid Therapeutic Market Research Report 2025

FEATURED COMPANIES

Nucleic Acid Therapeutic Market Size

Nucleic Acid Therapeutic Market

Scope of Nucleic Acid Therapeutic Market Report

Chapter Outline

FAQ for this report

How fast is Nucleic Acid Therapeutic Market growing?

What is the Nucleic Acid Therapeutic Market size in 2031?

Who are the main players in the Nucleic Acid Therapeutic Market report?

What are the Application segmentation covered in the Nucleic Acid Therapeutic Market report?

What are the Type segmentation covered in the Nucleic Acid Therapeutic Market report?

FEATURED COMPANIES